Anthony Bergmann insider trades

Open-market stock purchases and sales by Anthony Bergmann, CHIEF FINANCIAL OFFICER at Capricor Therapeutics, Inc, from SEC Form 4 filings since Oct 23, 2013.

Recent trades

DateStockTradeValue
Jun 25, 2026CAPR Capricor Therapeutics, IncSold$732K
Jun 25, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
Jun 24, 2026CAPR Capricor Therapeutics, IncSold$12K
Jun 24, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
Jun 22, 2026CAPR Capricor Therapeutics, IncSold$15K
Jun 22, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
May 18, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
May 1, 2026CAPR Capricor Therapeutics, IncSold$793K
May 1, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
Mar 31, 2026CAPR Capricor Therapeutics, IncSold$753K
Mar 31, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
Jan 5, 2026CAPR Capricor Therapeutics, IncBought (not open market)—
Jan 5, 2026CAPR Capricor Therapeutics, IncBought (not open market)—

Companies traded

  • CAPR Capricor Therapeutics, Inc: 2 buys, 5 sales, last Jun 25, 2026

Get free alerts when Anthony Bergmann files a new trade →